期刊文献+

鸡白痢沙门氏菌耐药性中药抑制剂的临床治疗效果 被引量:6

Clinical therapeutic effect of drug resistance traditional Chinese medicine inhibitor of Salmonella pullorum
下载PDF
导出
摘要 采用胸肌注射法对7日龄蛋雏鸡人工感染耐药菌株发病,分7组进行药物治疗试验,分别为抑制剂高剂量组、抑制剂中剂量组、抑制剂低剂量组、西药对照组(环丙沙星)、中药对照组(中药复方制剂)、阳性对照组(感染不给药)和阴性对照组(不感染不给药),饮水给药,连用7d,停药观察14d。结果表明,耐药抑制剂对感染鸡的死亡率降低到10%,治愈率达到70%,有效率达到90%,相对增重率达到101.18%。该耐药抑制剂对鸡耐药沙门氏菌感染具有良好的治疗作用。 The method of pectoral muscles injection was used to artificially infect 7 day-old chickens with drug resistant strain, then the chickens were divided into 7 groups: drug resistant inhibitor groups of high, middle and low doses; Western medicine control group(Ciprofloxacin); the traditional Chinese medicine control group (corn-pound preparation); positive control group (infected without treating); negative control group (no infecting and no treating), drinking water were administered in the medicines for 7 successive days, the chickens were observed for 14 d after the drug withdraw. The results showed that the death rate was 10%, the healing rate was 70%, the effective rate was 90%, and the relative weight gain rate was 101.18%. The conclusion was that this drug resistant inhibitor had a good therapeutic effect to the inhibitor-resistant Salmonella.
出处 《东北农业大学学报》 CAS CSCD 北大核心 2009年第1期89-91,共3页 Journal of Northeast Agricultural University
关键词 鸡白痢沙门氏菌 耐药性 中药抑制剂 治疗效果 Salmonella pullorum drug resistance traditional Chinese medicine inhibitor therapeutic effect
  • 相关文献

参考文献4

二级参考文献28

  • 1于录,邓旭明,李乾学,阎继业.外输泵介导的金黄色葡萄球菌对环丙沙星耐药性的确证[J].吉林农业大学学报,2005,27(3):335-338. 被引量:7
  • 2王如治.药剂学(第3版)[M].北京:人民卫生出版社,1997.125-135.
  • 3王如治.药剂学(第3版)[M].北京:人民卫生出版社,1997.125-135.
  • 4陈友梅.中药化学[M].济南:山东科学技术出版社,1988..
  • 5Linde H J,Notka F,Metz M. et al.In vivo increase in resistance to ciprofloxacin in Escherichia coli associated with deletion of the Cterminal part of MarR[J].Antimicrob Agents Chemother, 2000,44(7): 1865-1868.
  • 6Markham P N. Multiple novel inhibitors of the NorA multidrug transporter of Staphylococcusaureus[J]. Antimicrob Agents Chemother, 1999,43(10) :2404-2408.
  • 7Dantzig A H. Reversal of Muhidrug Resistance by the P-Glycoprorein Modulator, LY335979, from the Bench to the Clinic[J]. CurtMed Chem, 2001,8(1) :39-50.
  • 8Garuier-suillerot A. Analysis of Drug Transport Kinetics in Multidrug-resistant Cells: Implications for Drug Action C J]. Curr Med Chem, 2001,8( 1 ) :51-64.
  • 9Payen L. The sulphonylurea glibenclamide inhibits muhidrug resistance protein(MRP1) activity in human lung cancer cells [J]. Br J Pharmaco1,2001,132(3) :778-784.
  • 10Nacsa J.The inhibition of SOS-responses and MDR by phenothiafine-metal complexes[J]. Anticancer Res, 1998, 18(4):3093-3O98.

共引文献75

同被引文献35

引证文献6

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部